# Ilypsa

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ilypsa

- Industry: Pharmaceuticals
- Headquarters: Santa Clara, US
- Total disclosed funding: $46M
- Latest round: Series B (Jul 19, 2005)
- Investors on record: 7

## About

Ilypsa is a US-based company that operates as a developer of pharmaceutical products.

## Funding rounds

- Series B, Jul 19, 2005, $36M — Delphi Ventures, Mediphase Venture Partners, Sprout Group, US Venture Partners, Presidio Partners, 5AM Ventures, Johnson & Johnson Innovation
- Series A, Jun 1, 2003, $10M — Sprout Group, 5AM Ventures

## Investors

- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series A, Series B
- 5AM Ventures (https://capitalatlas.ai/funds/5am-ventures) — Series A, Series B
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series B
- Mediphase Venture Partners (https://capitalatlas.ai/funds/mediphase-venture-partners) — Series B
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series B
- Presidio Partners (https://capitalatlas.ai/funds/presidio-partners) — Series B
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series B